Enzolytics Inc (ENZC)

[falon]

Yes ENZC sold Shares to pay bills for the PAST ventures that didn't pan out.

Now we have the new ENZC that is not selling shares and is getting funding eleswhere.

The new ENZC is a product of the old ENZC plus BioClonetics with CEO Charles Cotropia running things.

It is still a penny stock on the OTC and a very RISKY investment.

Risk versus Reward:

Risk:

1. Technology Fails

2. Not enough funding to continue

3. Trials fails

4. No interest from Big Pharma

5. It is a scam

6. Daily trade volume low

Reward:

1. Technology Succeeds

2. Funding is Sufficient

3. Trials are Successful

4. HUGE interest from Big Pharma

5. It is a Legitimate Developmental Company with a very Bright future

6. Daily trade volume high

Either list could be longer however it would be a moot point.

The question is simple.

Based of the information avaliable which list is more appropriate at the PRESENT time?

Things may change in a week or a month to reflect more RISK than reward
or more REWARD than risk.

Today ENZC is in a REWARD phase.